Synergistic potential of α-Phellandrene combined with conventional antifungal agents and its mechanism against antibiotic resistant Candida albicans
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Synergistic potential of α-Phellandrene combined with conventional antifungal agents and its mechanism against antibiotic resistant Candida albicans ; volume:5 ; number:1 ; day:16 ; month:2 ; year:2024 ; pages:1-20 ; date:12.2024
CABI agriculture and bioscience ; 5, Heft 1 (16.2.2024), 1-20, 12.2024
- Creator
-
Bhattacharya, Riya
Sharma, Prashant
Bose, Debajyoti
Singh, Manish
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s43170-024-00218-1
- URN
-
urn:nbn:de:101:1-2404240838385.401701452218
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:58 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bhattacharya, Riya
- Sharma, Prashant
- Bose, Debajyoti
- Singh, Manish
- SpringerLink (Online service)
Other Objects (12)
Candida albicans and Antifungal Peptides
Liquid and vapour-phase antifungal activities of essential oils against Candida albicans and non-albicans Candida
Antifungal activity of MAF-1A peptide against Candida albicans
Synthetic arylquinuclidine derivatives exhibit antifungal activity against Candida albicans, Candida tropicalis and Candida parapsilopsis
Pharmacoeconomic analysis of antifungal therapy for primary treatment of invasive candidiasis caused by Candida albicans and non-albicans Candida species
Virulence and in vitro antifungal susceptibility of Candida albicans and Candida catenulata from laying hens
Antifungal Activity of Synthetic Scorpion Venom-Derived Peptide Analogues Against Candida albicans
Evolution of antifungal drug resistance of the human-pathogenic fungus Candida albicans
The newly synthesized thiazole derivatives as potential antifungal compounds against Candida albicans
Sensitization of Candida albicans biofilms to various antifungal drugs by cyclosporine A
Targeting Candida albicans O-acetyl-L-homoserine sulfhydrylase (Met15p) in antifungal treatment
Pulmonary surfactant impacts in vitro activity of selected antifungal drugs against Candida krusei and Candida albicans
Candida albicans and Antifungal Peptides
Liquid and vapour-phase antifungal activities of essential oils against Candida albicans and non-albicans Candida
Antifungal activity of MAF-1A peptide against Candida albicans
Synthetic arylquinuclidine derivatives exhibit antifungal activity against Candida albicans, Candida tropicalis and Candida parapsilopsis
Pharmacoeconomic analysis of antifungal therapy for primary treatment of invasive candidiasis caused by Candida albicans and non-albicans Candida species
Virulence and in vitro antifungal susceptibility of Candida albicans and Candida catenulata from laying hens
Antifungal Activity of Synthetic Scorpion Venom-Derived Peptide Analogues Against Candida albicans
Evolution of antifungal drug resistance of the human-pathogenic fungus Candida albicans
The newly synthesized thiazole derivatives as potential antifungal compounds against Candida albicans
Sensitization of Candida albicans biofilms to various antifungal drugs by cyclosporine A
Targeting Candida albicans O-acetyl-L-homoserine sulfhydrylase (Met15p) in antifungal treatment
Pulmonary surfactant impacts in vitro activity of selected antifungal drugs against Candida krusei and Candida albicans
Candida albicans and Antifungal Peptides
Liquid and vapour-phase antifungal activities of essential oils against Candida albicans and non-albicans Candida
Antifungal activity of MAF-1A peptide against Candida albicans
Synthetic arylquinuclidine derivatives exhibit antifungal activity against Candida albicans, Candida tropicalis and Candida parapsilopsis
Pharmacoeconomic analysis of antifungal therapy for primary treatment of invasive candidiasis caused by Candida albicans and non-albicans Candida species
Virulence and in vitro antifungal susceptibility of Candida albicans and Candida catenulata from laying hens
Antifungal Activity of Synthetic Scorpion Venom-Derived Peptide Analogues Against Candida albicans
Evolution of antifungal drug resistance of the human-pathogenic fungus Candida albicans
The newly synthesized thiazole derivatives as potential antifungal compounds against Candida albicans
Sensitization of Candida albicans biofilms to various antifungal drugs by cyclosporine A
Targeting Candida albicans O-acetyl-L-homoserine sulfhydrylase (Met15p) in antifungal treatment